

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.28858164 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.26912550 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.37926574 |
| 4 | myofibril assembly (GO:0030239) | 6.37470903 |
| 5 | muscle filament sliding (GO:0030049) | 5.92153076 |
| 6 | actin-myosin filament sliding (GO:0033275) | 5.92153076 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.78437648 |
| 8 | cardiac muscle cell development (GO:0055013) | 5.69826709 |
| 9 | cardiac cell development (GO:0055006) | 5.53407892 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.27485886 |
| 11 | plasma membrane repair (GO:0001778) | 5.22925410 |
| 12 | cardiac muscle contraction (GO:0060048) | 5.14982215 |
| 13 | actomyosin structure organization (GO:0031032) | 5.13273870 |
| 14 | actin-mediated cell contraction (GO:0070252) | 5.08592991 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.06902284 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.00805071 |
| 17 | regulation of skeletal muscle contraction (GO:0014819) | 4.96091907 |
| 18 | heart trabecula formation (GO:0060347) | 4.74584099 |
| 19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.70000333 |
| 20 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.61692418 |
| 21 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.54414803 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.54409951 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 4.39188412 |
| 24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.38987036 |
| 25 | muscle tissue morphogenesis (GO:0060415) | 4.38388068 |
| 26 | regulation of actin filament-based movement (GO:1903115) | 4.38338684 |
| 27 | tricarboxylic acid cycle (GO:0006099) | 4.33806540 |
| 28 | cardiac muscle hypertrophy (GO:0003300) | 4.21602996 |
| 29 | regulation of sarcomere organization (GO:0060297) | 4.19939105 |
| 30 | cellular response to epinephrine stimulus (GO:0071872) | 4.12731072 |
| 31 | actin filament-based movement (GO:0030048) | 4.09672860 |
| 32 | carnitine shuttle (GO:0006853) | 4.07366748 |
| 33 | adult heart development (GO:0007512) | 4.05463663 |
| 34 | striated muscle hypertrophy (GO:0014897) | 4.01537832 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.99152001 |
| 36 | striated muscle contraction (GO:0006941) | 3.94538485 |
| 37 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.86276193 |
| 38 | response to epinephrine (GO:0071871) | 3.85250639 |
| 39 | regulation of cardioblast differentiation (GO:0051890) | 3.81936782 |
| 40 | extracellular matrix assembly (GO:0085029) | 3.80488012 |
| 41 | cell communication involved in cardiac conduction (GO:0086065) | 3.77750562 |
| 42 | regulation of the force of heart contraction (GO:0002026) | 3.73823678 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.73757914 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 3.72609018 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.67512539 |
| 46 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.61706230 |
| 47 | fatty acid transmembrane transport (GO:1902001) | 3.60531490 |
| 48 | trabecula formation (GO:0060343) | 3.59341959 |
| 49 | muscle hypertrophy (GO:0014896) | 3.56053550 |
| 50 | relaxation of cardiac muscle (GO:0055119) | 3.54932332 |
| 51 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.52141813 |
| 52 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.50596499 |
| 53 | cGMP-mediated signaling (GO:0019934) | 3.44409207 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.43629437 |
| 55 | striated muscle adaptation (GO:0014888) | 3.41914801 |
| 56 | regulation of membrane repolarization (GO:0060306) | 3.34445173 |
| 57 | cardiac muscle cell proliferation (GO:0060038) | 3.31307336 |
| 58 | striated muscle cell development (GO:0055002) | 3.29051389 |
| 59 | relaxation of muscle (GO:0090075) | 3.27003392 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.26751192 |
| 61 | muscle contraction (GO:0006936) | 3.23622396 |
| 62 | cell migration involved in heart development (GO:0060973) | 3.22292012 |
| 63 | relaxation of smooth muscle (GO:0044557) | 3.20321668 |
| 64 | skeletal muscle contraction (GO:0003009) | 3.19492221 |
| 65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.18006493 |
| 66 | cell communication by electrical coupling (GO:0010644) | 3.15325669 |
| 67 | creatine metabolic process (GO:0006600) | 3.12509729 |
| 68 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.12193582 |
| 69 | regulation of ATP catabolic process (GO:1903289) | 3.12091496 |
| 70 | regulation of ATPase activity (GO:0043462) | 3.12091496 |
| 71 | cardiac chamber formation (GO:0003207) | 3.11744865 |
| 72 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.10023405 |
| 73 | cardiac muscle cell action potential (GO:0086001) | 3.09501853 |
| 74 | heart contraction (GO:0060047) | 3.08598054 |
| 75 | heart process (GO:0003015) | 3.08598054 |
| 76 | cardiac muscle adaptation (GO:0014887) | 3.07556430 |
| 77 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.07556430 |
| 78 | muscle hypertrophy in response to stress (GO:0003299) | 3.07556430 |
| 79 | regulation of cardiac muscle contraction (GO:0055117) | 3.06820039 |
| 80 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.05475009 |
| 81 | muscle system process (GO:0003012) | 3.03613882 |
| 82 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.03486384 |
| 83 | regulation of heart rate (GO:0002027) | 3.02468850 |
| 84 | negative regulation of potassium ion transport (GO:0043267) | 3.01920155 |
| 85 | hypotonic response (GO:0006971) | 3.01451016 |
| 86 | desmosome organization (GO:0002934) | 3.00014043 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 2.99983841 |
| 88 | carnitine transmembrane transport (GO:1902603) | 2.98150992 |
| 89 | regulation of muscle contraction (GO:0006937) | 2.94637721 |
| 90 | cardiac ventricle formation (GO:0003211) | 2.94269587 |
| 91 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.93958801 |
| 92 | regulation of heart contraction (GO:0008016) | 2.91500878 |
| 93 | response to inactivity (GO:0014854) | 2.90872787 |
| 94 | epithelial cell-cell adhesion (GO:0090136) | 2.89089383 |
| 95 | muscle cell development (GO:0055001) | 2.88636532 |
| 96 | regulation of fatty acid oxidation (GO:0046320) | 2.87851314 |
| 97 | muscle adaptation (GO:0043500) | 2.87216005 |
| 98 | positive regulation of myotube differentiation (GO:0010831) | 2.86415433 |
| 99 | response to caffeine (GO:0031000) | 2.85563400 |
| 100 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.83388985 |
| 101 | endocardial cushion morphogenesis (GO:0003203) | 2.83333867 |
| 102 | negative regulation of myotube differentiation (GO:0010832) | 2.80319097 |
| 103 | cardiac conduction (GO:0061337) | 2.80259984 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 2.80179248 |
| 105 | ventricular cardiac muscle cell development (GO:0055015) | 2.79051650 |
| 106 | regulation of coenzyme metabolic process (GO:0051196) | 2.78664503 |
| 107 | regulation of cofactor metabolic process (GO:0051193) | 2.78664503 |
| 108 | outflow tract septum morphogenesis (GO:0003148) | 2.78158024 |
| 109 | positive regulation of heart contraction (GO:0045823) | 2.77639840 |
| 110 | muscle fiber development (GO:0048747) | 2.77495777 |
| 111 | fibroblast migration (GO:0010761) | 2.77100739 |
| 112 | mesenchyme morphogenesis (GO:0072132) | 2.75048726 |
| 113 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.74307664 |
| 114 | negative regulation of heart growth (GO:0061117) | 2.74307664 |
| 115 | amino-acid betaine transport (GO:0015838) | 2.72673594 |
| 116 | carnitine transport (GO:0015879) | 2.72673594 |
| 117 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.71604422 |
| 118 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.71604422 |
| 119 | regulation of muscle system process (GO:0090257) | 2.71507697 |
| 120 | glucocorticoid biosynthetic process (GO:0006704) | 2.70023045 |
| 121 | urinary tract smooth muscle contraction (GO:0014848) | 2.69440432 |
| 122 | growth hormone secretion (GO:0030252) | 2.66268230 |
| 123 | skeletal muscle adaptation (GO:0043501) | 2.64192943 |
| 124 | positive regulation of vascular permeability (GO:0043117) | 2.61041380 |
| 125 | skeletal muscle tissue development (GO:0007519) | 2.60627342 |
| 126 | positive regulation of cation channel activity (GO:2001259) | 2.54091070 |
| 127 | striated muscle atrophy (GO:0014891) | 2.53686260 |
| 128 | regulation of myoblast differentiation (GO:0045661) | 2.47854089 |
| 129 | positive regulation of heart rate (GO:0010460) | 2.45034328 |
| 130 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.44685149 |
| 131 | muscle cell fate commitment (GO:0042693) | 2.44669374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.44830851 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.95991464 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.68190413 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.93034046 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.89427008 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.89271830 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.89271830 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68090496 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60503563 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.60356775 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.47443389 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.45120446 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.39708430 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.36691543 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.34683515 |
| 16 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.33199080 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33165873 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24619530 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.07183244 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.04575922 |
| 21 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.03939722 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03314204 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89754710 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88602926 |
| 25 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.87514406 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.84347244 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70190522 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68650405 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.67924517 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56263029 |
| 31 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.55882614 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53802055 |
| 33 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53475294 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.52497453 |
| 35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.51745197 |
| 36 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50309904 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49068127 |
| 38 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.46057628 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43794373 |
| 40 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43304413 |
| 41 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42419437 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41785201 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40913696 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40728647 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39657254 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39009883 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38921390 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38217777 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38074362 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36665097 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36665097 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36371930 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35896009 |
| 54 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.33428580 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32084124 |
| 56 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31141264 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31083532 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30877174 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30231216 |
| 60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28102367 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27648777 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24018741 |
| 63 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.24017157 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23779260 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22918253 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22887231 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22063104 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22063104 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21612978 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20465187 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20306916 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18925567 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18627130 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18530749 |
| 75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18480923 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16701489 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16672150 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16593085 |
| 79 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15704370 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13092434 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10625623 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10268368 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10065311 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09737002 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08404741 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06963527 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06536250 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06496413 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06496413 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06404133 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02177053 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02085441 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01496188 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01169225 |
| 95 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99797133 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99586901 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99340042 |
| 98 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99051321 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99006031 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99004597 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98328841 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96639330 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96392895 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96189904 |
| 105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96000731 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94862074 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94639283 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94413839 |
| 109 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94337780 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94166262 |
| 111 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93602541 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93599761 |
| 113 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93591620 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93559551 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93382820 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93267424 |
| 117 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92636345 |
| 118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92431592 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92229785 |
| 120 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90723064 |
| 121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90399584 |
| 122 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89690630 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89584849 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89421767 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89218378 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89184255 |
| 127 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89106138 |
| 128 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88709038 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88294351 |
| 130 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87638273 |
| 131 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87459071 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87059778 |
| 133 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87054817 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86990111 |
| 135 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85621695 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85310481 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85121839 |
| 138 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.83950687 |
| 139 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83839851 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83557257 |
| 141 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82881489 |
| 142 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.82646853 |
| 143 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82319754 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82283166 |
| 145 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80521662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.17599388 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.07511855 |
| 3 | MP0000751_myopathy | 4.51035740 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.89296942 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.82301492 |
| 6 | MP0005330_cardiomyopathy | 3.62969593 |
| 7 | MP0003646_muscle_fatigue | 3.43801312 |
| 8 | MP0000749_muscle_degeneration | 3.11686549 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.80277356 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.77889971 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.66947335 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.61350958 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.46917757 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.40357008 |
| 15 | MP0010630_abnormal_cardiac_muscle | 2.38567481 |
| 16 | MP0003137_abnormal_impulse_conducting | 2.28746968 |
| 17 | MP0001544_abnormal_cardiovascular_syste | 2.23338055 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.23338055 |
| 19 | MP0006138_congestive_heart_failure | 2.21601681 |
| 20 | MP0004484_altered_response_of | 2.16896256 |
| 21 | MP0004130_abnormal_muscle_cell | 2.16890436 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.00240438 |
| 23 | MP0003828_pulmonary_edema | 1.99541911 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.97713524 |
| 25 | MP0005275_abnormal_skin_tensile | 1.87057109 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.86147735 |
| 27 | MP0002269_muscular_atrophy | 1.77804658 |
| 28 | MP0004085_abnormal_heartbeat | 1.76582704 |
| 29 | MP0005369_muscle_phenotype | 1.71849962 |
| 30 | MP0004272_abnormal_basement_membrane | 1.71357621 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.66903349 |
| 32 | MP0000747_muscle_weakness | 1.60569759 |
| 33 | MP0003279_aneurysm | 1.59215404 |
| 34 | MP0005595_abnormal_vascular_smooth | 1.51314995 |
| 35 | MP0005503_abnormal_tendon_morphology | 1.44298068 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.43554495 |
| 37 | MP0001958_emphysema | 1.41223559 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.37144958 |
| 39 | MP0001661_extended_life_span | 1.35035660 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.33503755 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.33010412 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.31922543 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 1.30319758 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.29544868 |
| 45 | MP0004233_abnormal_muscle_weight | 1.28407797 |
| 46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27711778 |
| 47 | MP0000733_abnormal_muscle_development | 1.22676303 |
| 48 | MP0004510_myositis | 1.22446181 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.19871101 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.15076760 |
| 51 | MP0005367_renal/urinary_system_phenotyp | 1.14925724 |
| 52 | MP0000516_abnormal_urinary_system | 1.14925724 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.14656253 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.14421295 |
| 55 | MP0000266_abnormal_heart_morphology | 1.13744800 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.13076884 |
| 57 | MP0003724_increased_susceptibility_to | 1.12078145 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.07840011 |
| 59 | MP0006054_spinal_hemorrhage | 1.06509226 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.05483703 |
| 61 | MP0001664_abnormal_digestion | 1.05025522 |
| 62 | MP0005451_abnormal_body_composition | 1.04544756 |
| 63 | MP0000534_abnormal_ureter_morphology | 1.02440454 |
| 64 | MP0000537_abnormal_urethra_morphology | 1.00372449 |
| 65 | MP0000343_altered_response_to | 0.97376902 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.97088119 |
| 67 | MP0000230_abnormal_systemic_arterial | 0.96765942 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.95901458 |
| 69 | MP0003941_abnormal_skin_development | 0.94780627 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 0.94248518 |
| 71 | MP0003879_abnormal_hair_cell | 0.93017514 |
| 72 | MP0002128_abnormal_blood_circulation | 0.91847581 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.90474781 |
| 74 | MP0005165_increased_susceptibility_to | 0.88338960 |
| 75 | MP0003303_peritoneal_inflammation | 0.88273723 |
| 76 | MP0003385_abnormal_body_wall | 0.85382709 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.85192782 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.81322508 |
| 79 | MP0003878_abnormal_ear_physiology | 0.81322508 |
| 80 | MP0002933_joint_inflammation | 0.78853634 |
| 81 | MP0002254_reproductive_system_inflammat | 0.78294167 |
| 82 | MP0003045_fibrosis | 0.77622741 |
| 83 | MP0005164_abnormal_response_to | 0.76022183 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 0.75443724 |
| 85 | MP0005670_abnormal_white_adipose | 0.73730093 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.73403971 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.71156241 |
| 88 | MP0002168_other_aberrant_phenotype | 0.71044938 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.70969059 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.70859127 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 0.69779938 |
| 92 | MP0004147_increased_porphyrin_level | 0.69543637 |
| 93 | MP0005187_abnormal_penis_morphology | 0.68630829 |
| 94 | MP0005023_abnormal_wound_healing | 0.68598970 |
| 95 | MP0002971_abnormal_brown_adipose | 0.68408429 |
| 96 | MP0000249_abnormal_blood_vessel | 0.66595665 |
| 97 | MP0001756_abnormal_urination | 0.65707193 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.65523253 |
| 99 | MP0001614_abnormal_blood_vessel | 0.65201833 |
| 100 | MP0000428_abnormal_craniofacial_morphol | 0.65201713 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 0.64901204 |
| 102 | MP0000462_abnormal_digestive_system | 0.64620727 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.63259428 |
| 104 | MP0001270_distended_abdomen | 0.61996241 |
| 105 | MP0002249_abnormal_larynx_morphology | 0.61416990 |
| 106 | MP0009115_abnormal_fat_cell | 0.58732174 |
| 107 | MP0000762_abnormal_tongue_morphology | 0.58544695 |
| 108 | MP0003935_abnormal_craniofacial_develop | 0.58063735 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.57693862 |
| 110 | MP0000538_abnormal_urinary_bladder | 0.57289961 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.57189866 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.56843986 |
| 113 | MP0005266_abnormal_metabolism | 0.56514397 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.55621584 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.55123696 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.54314940 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.51263590 |
| 118 | MP0008004_abnormal_stomach_pH | 0.51018089 |
| 119 | MP0003942_abnormal_urinary_system | 0.50448539 |
| 120 | MP0003091_abnormal_cell_migration | 0.49541715 |
| 121 | MP0002115_abnormal_skeleton_extremities | 0.48974363 |
| 122 | MP0002060_abnormal_skin_morphology | 0.48655782 |
| 123 | MP0005390_skeleton_phenotype | 0.46441232 |
| 124 | MP0005166_decreased_susceptibility_to | 0.46217949 |
| 125 | MP0005409_darkened_coat_color | 0.42675929 |
| 126 | MP0004883_abnormal_blood_vessel | 0.42628906 |
| 127 | MP0005171_absent_coat_pigmentation | 0.41897023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.09633217 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.74461643 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.23056021 |
| 4 | Muscle fiber splitting (HP:0003555) | 5.22213057 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.16082632 |
| 6 | Abnormality of the calf musculature (HP:0001430) | 4.96805361 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.81279518 |
| 8 | Atrial fibrillation (HP:0005110) | 4.79868677 |
| 9 | Lipoatrophy (HP:0100578) | 4.62455748 |
| 10 | Aortic aneurysm (HP:0004942) | 4.59499742 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.56757818 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.45307771 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 4.30082572 |
| 14 | Supraventricular tachycardia (HP:0004755) | 4.26159235 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 4.23739650 |
| 16 | Exercise-induced myalgia (HP:0003738) | 4.20061209 |
| 17 | Aortic dissection (HP:0002647) | 4.02328423 |
| 18 | Increased connective tissue (HP:0009025) | 4.00385084 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.88528349 |
| 20 | Facial diplegia (HP:0001349) | 3.82480825 |
| 21 | Subaortic stenosis (HP:0001682) | 3.82320344 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.82320344 |
| 23 | Syncope (HP:0001279) | 3.80347660 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 3.66844078 |
| 25 | Bundle branch block (HP:0011710) | 3.66669672 |
| 26 | Palpitations (HP:0001962) | 3.49869179 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.49560193 |
| 28 | Prolonged QT interval (HP:0001657) | 3.44180617 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.33784806 |
| 30 | Ventricular arrhythmia (HP:0004308) | 3.31219717 |
| 31 | Myoglobinuria (HP:0002913) | 3.30702489 |
| 32 | Broad metatarsal (HP:0001783) | 3.08097641 |
| 33 | Atrioventricular block (HP:0001678) | 3.08045565 |
| 34 | Heart block (HP:0012722) | 3.06303401 |
| 35 | Scapular winging (HP:0003691) | 3.02367083 |
| 36 | Ankle contracture (HP:0006466) | 3.02203331 |
| 37 | Difficulty running (HP:0009046) | 2.97738293 |
| 38 | Hypoplastic ischia (HP:0003175) | 2.97527632 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 2.95436002 |
| 40 | Increased density of long bones (HP:0006392) | 2.95030147 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.88520799 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.86670399 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.84139818 |
| 44 | Difficulty climbing stairs (HP:0003551) | 2.83047620 |
| 45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.80815530 |
| 46 | Papilledema (HP:0001085) | 2.77843100 |
| 47 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.77605230 |
| 48 | Areflexia of lower limbs (HP:0002522) | 2.74217019 |
| 49 | Myotonia (HP:0002486) | 2.70965916 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.65925952 |
| 51 | Aneurysm (HP:0002617) | 2.63424964 |
| 52 | Abnormality of the ischium (HP:0003174) | 2.61926559 |
| 53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.53286442 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.49248643 |
| 55 | Bulbar palsy (HP:0001283) | 2.47545932 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.46540712 |
| 57 | Testicular atrophy (HP:0000029) | 2.43583255 |
| 58 | Ulnar deviation of the wrist (HP:0003049) | 2.37335982 |
| 59 | Hip contracture (HP:0003273) | 2.33083959 |
| 60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.29808174 |
| 61 | Premature rupture of membranes (HP:0001788) | 2.29802773 |
| 62 | Protrusio acetabuli (HP:0003179) | 2.29721111 |
| 63 | Bicuspid aortic valve (HP:0001647) | 2.28385992 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.26858263 |
| 65 | Complement deficiency (HP:0004431) | 2.25930556 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.25655492 |
| 67 | Abnormal EKG (HP:0003115) | 2.25626655 |
| 68 | Neck muscle weakness (HP:0000467) | 2.20293634 |
| 69 | Frequent falls (HP:0002359) | 2.18802792 |
| 70 | Muscle fiber inclusion bodies (HP:0100299) | 2.13976410 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.07683083 |
| 72 | Malnutrition (HP:0004395) | 2.05991747 |
| 73 | Lymphangioma (HP:0100764) | 2.05667804 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 2.05504990 |
| 75 | Round ear (HP:0100830) | 2.04220793 |
| 76 | Palmoplantar keratoderma (HP:0000982) | 2.04220335 |
| 77 | Spinal rigidity (HP:0003306) | 2.01583621 |
| 78 | Knee flexion contracture (HP:0006380) | 1.97789773 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 1.97223898 |
| 80 | Dysmetric saccades (HP:0000641) | 1.96230069 |
| 81 | Foot dorsiflexor weakness (HP:0009027) | 1.95117859 |
| 82 | Long toe (HP:0010511) | 1.94620371 |
| 83 | Left ventricular hypertrophy (HP:0001712) | 1.92532027 |
| 84 | Steppage gait (HP:0003376) | 1.91709008 |
| 85 | Persistence of primary teeth (HP:0006335) | 1.91030682 |
| 86 | Shallow orbits (HP:0000586) | 1.91001649 |
| 87 | Stroke (HP:0001297) | 1.89615071 |
| 88 | Vascular tortuosity (HP:0004948) | 1.89363080 |
| 89 | Generalized muscle weakness (HP:0003324) | 1.88733637 |
| 90 | Bradycardia (HP:0001662) | 1.88300979 |
| 91 | Myopathic facies (HP:0002058) | 1.88218581 |
| 92 | Distal arthrogryposis (HP:0005684) | 1.88190897 |
| 93 | Abnormality of the 4th metacarpal (HP:0010012) | 1.87062664 |
| 94 | Hypoplasia of the iris (HP:0007676) | 1.86153593 |
| 95 | Rectal prolapse (HP:0002035) | 1.85746490 |
| 96 | Gowers sign (HP:0003391) | 1.84781055 |
| 97 | Conjunctival hamartoma (HP:0100780) | 1.84417508 |
| 98 | Proximal amyotrophy (HP:0007126) | 1.83758516 |
| 99 | Limited hip movement (HP:0008800) | 1.83386802 |
| 100 | Absent phalangeal crease (HP:0006109) | 1.83094081 |
| 101 | Ketoacidosis (HP:0001993) | 1.82699812 |
| 102 | Sudden cardiac death (HP:0001645) | 1.82497506 |
| 103 | Short hallux (HP:0010109) | 1.79288282 |
| 104 | Neoplasm of the heart (HP:0100544) | 1.78695949 |
| 105 | Calcaneovalgus deformity (HP:0001848) | 1.78692754 |
| 106 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.78045752 |
| 107 | Broad ribs (HP:0000885) | 1.77960195 |
| 108 | Abnormality of complement system (HP:0005339) | 1.76493508 |
| 109 | Overgrowth (HP:0001548) | 1.75721448 |
| 110 | Bell-shaped thorax (HP:0001591) | 1.75624440 |
| 111 | Abnormality of the pubic bones (HP:0003172) | 1.72458937 |
| 112 | Mitral valve prolapse (HP:0001634) | 1.71599642 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71171809 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 1.71171809 |
| 115 | Dilatation of the ascending aorta (HP:0005111) | 1.70855295 |
| 116 | Nemaline bodies (HP:0003798) | 1.70662885 |
| 117 | Hematochezia (HP:0002573) | 1.68217741 |
| 118 | Wrist flexion contracture (HP:0001239) | 1.67936310 |
| 119 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.67666435 |
| 120 | Congestive heart failure (HP:0001635) | 1.67259996 |
| 121 | Hamartoma of the eye (HP:0010568) | 1.66123290 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.65972866 |
| 123 | Hypoglycemic coma (HP:0001325) | 1.65867915 |
| 124 | Muscular dystrophy (HP:0003560) | 1.62415773 |
| 125 | EMG: neuropathic changes (HP:0003445) | 1.61928445 |
| 126 | Gastrointestinal dysmotility (HP:0002579) | 1.60826179 |
| 127 | Aortic regurgitation (HP:0001659) | 1.60523259 |
| 128 | Limb-girdle muscle weakness (HP:0003325) | 1.59903726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.36291899 |
| 2 | MYLK | 6.02392240 |
| 3 | DMPK | 3.75110038 |
| 4 | LMTK2 | 3.63019485 |
| 5 | TRIB3 | 3.14991677 |
| 6 | DDR2 | 3.02008696 |
| 7 | PKN2 | 2.71257278 |
| 8 | OBSCN | 2.54060449 |
| 9 | PHKG2 | 2.49293267 |
| 10 | PHKG1 | 2.49293267 |
| 11 | PIK3CA | 2.11955297 |
| 12 | PDK4 | 2.05897704 |
| 13 | PDK3 | 2.05897704 |
| 14 | LATS1 | 1.98125629 |
| 15 | RIPK1 | 1.69621032 |
| 16 | PDGFRA | 1.60772178 |
| 17 | TIE1 | 1.60222258 |
| 18 | PDK2 | 1.58488112 |
| 19 | BCKDK | 1.53352300 |
| 20 | SIK1 | 1.47650207 |
| 21 | PIK3CG | 1.33931078 |
| 22 | PAK2 | 1.31694405 |
| 23 | ILK | 1.28815286 |
| 24 | STK39 | 1.23550441 |
| 25 | PAK3 | 1.22654078 |
| 26 | ROCK1 | 1.21939163 |
| 27 | TGFBR2 | 1.20054192 |
| 28 | CDC42BPA | 1.19999454 |
| 29 | MAPKAPK3 | 1.12862067 |
| 30 | TRPM7 | 1.11146509 |
| 31 | FRK | 1.06058963 |
| 32 | NLK | 1.05295940 |
| 33 | PTK6 | 1.01784116 |
| 34 | EEF2K | 1.01515068 |
| 35 | MUSK | 0.99035242 |
| 36 | STK24 | 0.97750645 |
| 37 | EPHB2 | 0.97641910 |
| 38 | AKT3 | 0.97502559 |
| 39 | STK38L | 0.95810583 |
| 40 | MOS | 0.95354383 |
| 41 | PRKD1 | 0.94654967 |
| 42 | NEK1 | 0.92964716 |
| 43 | MAP3K6 | 0.90618470 |
| 44 | DAPK3 | 0.89801382 |
| 45 | FER | 0.87819321 |
| 46 | MAPK7 | 0.87318448 |
| 47 | EPHB1 | 0.80871347 |
| 48 | ROCK2 | 0.80776237 |
| 49 | CAMK2D | 0.78545110 |
| 50 | MAP3K7 | 0.76700839 |
| 51 | WNK4 | 0.75580741 |
| 52 | LIMK1 | 0.73832286 |
| 53 | MAPK4 | 0.73710072 |
| 54 | MARK2 | 0.72552923 |
| 55 | WNK1 | 0.72531568 |
| 56 | LRRK2 | 0.71933236 |
| 57 | EPHA3 | 0.70072061 |
| 58 | NUAK1 | 0.69927176 |
| 59 | ERN1 | 0.67877709 |
| 60 | SGK2 | 0.67396200 |
| 61 | RPS6KL1 | 0.64477574 |
| 62 | RPS6KC1 | 0.64477574 |
| 63 | LATS2 | 0.64292610 |
| 64 | INSRR | 0.63108925 |
| 65 | MAP3K3 | 0.62484797 |
| 66 | PTK2B | 0.61312505 |
| 67 | MELK | 0.60760190 |
| 68 | PINK1 | 0.58192856 |
| 69 | FGFR2 | 0.53920762 |
| 70 | PRKAA2 | 0.53602731 |
| 71 | PRKAA1 | 0.53481353 |
| 72 | MAP3K10 | 0.53195758 |
| 73 | FLT3 | 0.52875410 |
| 74 | MAPK12 | 0.52146575 |
| 75 | RPS6KA6 | 0.51906090 |
| 76 | STK38 | 0.51400681 |
| 77 | SGK3 | 0.51144692 |
| 78 | RPS6KA2 | 0.49852302 |
| 79 | MARK3 | 0.48945281 |
| 80 | CAMK2G | 0.48556855 |
| 81 | MAP3K5 | 0.48231170 |
| 82 | FGFR3 | 0.47364349 |
| 83 | MTOR | 0.47192686 |
| 84 | STK3 | 0.46294659 |
| 85 | GRK7 | 0.45962151 |
| 86 | PDGFRB | 0.44184284 |
| 87 | STK4 | 0.43555097 |
| 88 | CAMK2A | 0.43335252 |
| 89 | KDR | 0.42975435 |
| 90 | ZAK | 0.42457861 |
| 91 | SGK494 | 0.42403623 |
| 92 | SGK223 | 0.42403623 |
| 93 | ICK | 0.41724736 |
| 94 | NEK9 | 0.40728544 |
| 95 | MAP2K3 | 0.40443166 |
| 96 | PRKD2 | 0.40008604 |
| 97 | CAMK1D | 0.39535688 |
| 98 | PRKACB | 0.39441047 |
| 99 | TESK1 | 0.39237561 |
| 100 | MET | 0.38423953 |
| 101 | CAMK4 | 0.37235055 |
| 102 | CAMK1G | 0.36086413 |
| 103 | CAMK1 | 0.36067246 |
| 104 | PTK2 | 0.35957103 |
| 105 | PRKG1 | 0.35822764 |
| 106 | CAMK2B | 0.34212493 |
| 107 | ACVR1B | 0.34014999 |
| 108 | MAP3K13 | 0.33775240 |
| 109 | RET | 0.33059378 |
| 110 | FGFR4 | 0.32525597 |
| 111 | JAK1 | 0.31849183 |
| 112 | FGFR1 | 0.31768936 |
| 113 | PKN1 | 0.30669757 |
| 114 | PRKCH | 0.30061813 |
| 115 | ADRBK1 | 0.29508672 |
| 116 | BLK | 0.28641807 |
| 117 | TBK1 | 0.27866010 |
| 118 | PDPK1 | 0.27747308 |
| 119 | PRKACA | 0.27562274 |
| 120 | PRKCE | 0.26885978 |
| 121 | MAP3K1 | 0.26775017 |
| 122 | MAP2K1 | 0.26717278 |
| 123 | PRKACG | 0.26434712 |
| 124 | JAK2 | 0.26321915 |
| 125 | RPS6KA1 | 0.25186601 |
| 126 | GSK3A | 0.24211037 |
| 127 | PAK4 | 0.23879714 |
| 128 | AKT2 | 0.23626121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.58343063 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.85649838 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.82992326 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.38775917 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.32367454 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.80157347 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.62638887 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54481723 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20757688 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.06133653 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 1.98916072 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92713185 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87136335 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.72665276 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71671422 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.63734158 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61663207 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51491370 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50994306 |
| 20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.49919583 |
| 21 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.46169839 |
| 22 | Tight junction_Homo sapiens_hsa04530 | 1.35294774 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34095441 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33620671 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33327069 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.32577865 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.31376804 |
| 28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30382360 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25087491 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20244291 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.16262396 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14940850 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.14212092 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09443299 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06347950 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98313995 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 0.96358899 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96043552 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95091729 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93544844 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 0.92072073 |
| 42 | Malaria_Homo sapiens_hsa05144 | 0.91424326 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89508658 |
| 44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88798732 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88264516 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85860486 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85653535 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84933532 |
| 49 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.83179285 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81920201 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81369381 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81257382 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81232227 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80845744 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80213365 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79082644 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78760128 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78596758 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.75653679 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.75173760 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74685840 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73201154 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72658106 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70877319 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70430593 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69414048 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.68084033 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68059652 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66848013 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.66303028 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65819892 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64948255 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63104251 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62764485 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62287310 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62118479 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.61769700 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60016031 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58989853 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58402084 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.57846689 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57550353 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56209660 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55894211 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55676815 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55664642 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55515884 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53137540 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52239026 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52014991 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51197177 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51070862 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50375790 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49969292 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49958464 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49384628 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48875139 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48514763 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47383246 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46784350 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45642464 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45525821 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44488999 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.43995396 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43020514 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42344653 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42292429 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42263301 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41635049 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41119664 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41033625 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40924103 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40864654 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40409799 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.40386905 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40255868 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39955773 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.38577561 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37630736 |
| 120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36775133 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.36098008 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.35412684 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35361696 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35333346 |
| 125 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35130384 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34773593 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33899182 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.33300971 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31392206 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31336920 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31237668 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30934527 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28674960 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28647364 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.28586378 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27668256 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25839517 |

